Skandinaviska Enskilda Banken (SEB)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$723K	–	998
2023 Q1	$723K	Buy	+30,000	New	+$376K	0.01%	729

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PRVB Position: Q2 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 30,000 shares — an estimated $723K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $723K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Skandinaviska Enskilda Banken (SEB) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 30,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $723K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Provention Bio, Inc. Common Stock position peaked at $723K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2023, filed 7 Aug 2023.